Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Non-Current Liabilities (2021 - 2025)

Core Scientific's Other Non-Current Liabilities history spans 5 years, with the latest figure at $364.6 million for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 64.16% year-over-year to $364.6 million; the TTM value through Sep 2025 reached $364.6 million, down 64.16%, while the annual FY2024 figure was $1.1 billion, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $364.6 million at Core Scientific, down from $1.3 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.3 billion in Q2 2025 and bottomed at $2.2 million in Q4 2022.
  • The 5-year median for Other Non-Current Liabilities is $39.4 million (2021), against an average of $336.5 million.
  • The largest annual shift saw Other Non-Current Liabilities crashed 88.07% in 2022 before it surged 11828.7% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $18.5 million in 2021, then plummeted by 88.07% to $2.2 million in 2022, then changed by 0.0% to $2.2 million in 2023, then soared by 49550.9% to $1.1 billion in 2024, then tumbled by 66.77% to $364.6 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Other Non-Current Liabilities are $364.6 million (Q3 2025), $1.3 billion (Q2 2025), and $421.9 million (Q1 2025).